X0206 3 2022-01-01 0 0000064803 CVS HEALTH Corp CVS 0001900910 Shah Prem S ONE CVS DRIVE WOONSOCKET RI 02895 1 EVP and Co-President of Retail Common Stock 11980.24 D Common Stock (restricted) 575 D Common Stock (restricted) 2884 D Common Stock (restricted) 15427 D Common Stock (restricted) 1808 D Common Stock (restricted) 1925 D Common Stock (restricted) 6393 D Common Stock (restricted) 4372.62 D Common Stock (restricted) 2798 D Stock Unit (deferred) 5625.28 D Stock Option 104.82 2017-04-01 2023-04-01 Common Stock 5870 D Stock Option 102.26 2016-04-01 2022-04-01 Common Stock 5346 D Stock Option 62.2011 2019-04-01 2025-04-01 Common Stock 1691 D Stock Option 54.19 2020-04-01 2029-04-01 Common Stock 12626 D Stock Option 58.34 2021-04-01 2030-04-01 Common Stock 34315 D Stock Option 74.30 2022-04-01 2031-04-01 Common Stock 32826 D Stock Option 75.24 2021-08-31 2028-08-31 Common Stock 26580 D Consists of remaining Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan (ICP). Restrictions lapse on 02/28/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in two equal installments commencing on 04/01/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in three equal installments commencing on 04/01/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions lapse on 04/01/2022. Consists of remaining RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 ICP. Restrictions lapse in two equal installments commencing on 02/28/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in four equal installments commencing on 04/01/2022. Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023. Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions lapse in three equal installments commencing on 02/26/2022. Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer. Option becomes exercisable in four equal installments commencing 04/01/2017. Option becomes exercisable in four equal installments commencing 04/01/2016. Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised. Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised. Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised. Option becomes exercisable in three equal installments commencing 04/01/2022. Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023. /s/ Prem S. Shah 2022-01-10